Live Breaking News & Updates on San Diego Superior Court The

Last year, the California Supreme Court held in
Ixchel Pharma, LLC v. Biogen, Inc., that restraints in contracts between businesses should be evaluated using the same “rule of reason” standard that courts use to analyze antitrust violations under the Cartwright Act. Our previous article analyzing the
Ixchel decision can be found here.
 
Recently, in
Ixchel to overturn a decision of the San Diego Superior Court (the “Superior Court”).
Procedural History
The case arises from a dispute over an exclusivity provision contained in a business agreement (the “Agreement”) entered into between two biotechnology companies, Quidel Corporation (“Quidel”) and Beckman Coulter, Inc. (“Beckman”).[1] Under the terms of the Agreement, Beckman became the exclusive developer of a B-type natriuretic peptide (BNP) assay for Quidel. Quidel would use these assays in a specially designed analyzer to help diagnose congestive heart failure. Section 5.2.3 of ....

United States , San Diego , San Diego County , Appeals Court Decision , Ixchel Pharma , Secrets Group , Biosite Inc , Biogen Inc , Quidel Corporation , Appeals For The Fourth District Court , San Diego Superior Court The , California Supreme Court , California Court , Beckman Coulter Inc , Superior Court , Fourth District , San Diego Superior Court , Beckman Coulter , California Business , Professions Code , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , சான் டியாகோ கவுண்டி , முறையீடுகள் நீதிமன்றம் முடிவு , இக்ஷ்செல் பார்மா , ரகசியங்கள் குழு ,